Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.620
+0.060 (1.32%)
Jun 27, 2025, 4:00 PM - Market closed
Olema Pharmaceuticals Stock Forecast
OLMA's stock price has decreased by -58.23% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Olema Pharmaceuticals stock ranges from a low of $18 to a high of $30. The average analyst price target of $24.5 forecasts a 430.30% increase in the stock price over the next year.
Price Target: $24.50 (+430.30%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2025.
Analyst Ratings
The average analyst rating for Olema Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +289.61% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | +376.19% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +549.35% | Apr 28, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $30 → $28 | Buy | Maintains | $30 → $28 | +506.06% | Mar 28, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $30 → $25 | Buy | Reiterates | $30 → $25 | +441.13% | Mar 19, 2025 |
Financial Forecast
Revenue This Year
n/a
from 340.22M
Revenue Next Year
n/a
EPS This Year
-1.74
from -2.20
EPS Next Year
-1.97
from -1.74
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 23.6M | 52.5M | ||
| Avg | n/a | 3.8M | 30.3M | ||
| Low | n/a | n/a | 13.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 1,272.5% | ||
| Avg | - | - | 691.4% | ||
| Low | - | - | 263.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.61 | -1.49 | -1.92 |
| Avg | -1.74 | -1.97 | -2.03 |
| Low | -2.19 | -2.18 | -2.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.